Improving AAV and LV Upstream GMP Manufacturing

The data in this poster demonstrate that VirusGEN® pushes the limits of high titer recombinant AAV and LV production to provide more usable virus per run, maximizing precious time and resources.

Please complete the form below to download this poster. Thank you for your interest!

First Name:

Last Name:

Institution/Company:

Institution Type:

Country:

Email:

I consent to receive newsletters and emails from Mirus Bio. For further information, please consult the Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Google Terms of Service apply.

Like this paper? We have more content like it!

Visit our blog: The TransMission

Or, sign up for our Transfection Connection newsletter below!

Improving AAV and LV Upstream GMP Manufacturing

Please Wait...